APT-TBI-01, NCT05826912: Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury |
|
|
| Enrolling by invitation | 2 | 672 | US | Atorvastatin Calcium, ATOR, Minocycline Hydrochloride, MINO, Candesartan Cilexetil, CAND, Placebo | University of California, San Francisco, United States Department of Defense | Traumatic Brain Injury | 08/28 | 08/29 | | |
NCT04602806: Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Phase 2 Option 1 |
|
|
| Completed | N/A | 50 | US | | University of California, San Francisco, U.S. Army Medical Research and Development Command | Traumatic Brain Injury | 11/22 | 01/23 | | |